arrow
P

Perrine Janiaud

research center for clinical neuroimmunology and neuroscience basel
H指数:24
被引数:2,535

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Mixed-methods process evaluation of ctDNA use to guide decision-making in patients with advanced solid cancers: study protocol for a substudy of the LIQPLAT trial

ctDNA用于指导晚期实体癌患者决策的混合方法过程评估: LIQPLAT试验子研究的研究方案

2025-10-270
OA
Retrospective use of the PRECIS-2 trial design tool to assess design choices in randomised controlled trials; An empirical review

运用PRECIS-2试验设计工具对随机对照试验的设计选择进行回顾性评估;一项实证综述

2025-09-010
OAAI
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials (vol 12, 2349, 2021)

羟氯喹和氯喹在新型冠状病毒肺炎中的死亡率结果: 一项随机试验的国际合作荟萃分析 (第12卷,2349,2021卷)

2024-02-050
OAAI
Effects of remdesivir in patients hospitalised with COVID-19 a systematic review and individual patient data meta- analysis of randomised controlled trials

remdesivir对新型冠状病毒肺炎住院患者的影响随机对照试验的系统评价和个体患者数据荟萃分析

2023-05-0165
OAAI
Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials

新型冠状病毒肺炎恢复期血浆治疗与死亡率的关系: 一项随机临床试验的协作系统评价和荟萃分析

2021-11-2050
OAAI
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials (vol 12, 2349, 2021)

羟氯喹和氯喹在新型冠状病毒肺炎中的死亡率结果: 一项随机试验的国际合作荟萃分析 (第12卷,2349,2021卷)

2021-05-1411
OAAI
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

羟氯喹和氯喹治疗新型冠状病毒肺炎的死亡率结果: 一项随机试验的国际合作荟萃分析

2021-04-15198
OAAI